E.AllenD
Following a sermorelin dose, the increase in circulating GH leads to a corresponding rise in IGF-1 production primarily from the liver, which mediates many of the growth-promoting and metabolic effects of GH
PubChem Reference: View compound profile on NIH PubChem Key Characteristics MOLECULAR PROFILE Formula: C 78 H 123 N 23 O 23 S 2 Weight: 1815.12 g/mol CAS: 221231-10-3 Origin: hGH 177-191 + N-terminal tyrosine Structure: Modified peptide with disulfide bridge PHYSICAL PROPERTIES Form: White to off-white lyophilized powder Solubility: Readily soluble in water Stability: Excellent with disulfide bridge Storage: Keep refrigerated 3646 F (28 C) Related products NAD+ $40.00 $125.00Price range: $40.00 through $125.00 Thymulin $45.00 $65.00Price range: $45.00 through $65.00
Regular tracking during extended protocols should include periodic reassessment of laboratory parameters (glucose body function, liver and kidney function, lipid profile, complete blood count), growth factor levels (IGF-1, IGFBP-3, possibly growth hormone), body makeup and research-specific outcomes, and screening for possible adverse effects
The technique requires longer needles than subcutaneous injections and carries slightly higher discomfort potential
